Cellestial Health
Preclinical small-molecule therapies targeting astrocytic networks for Parkinson’s and other neurological diseases
Highlights
- Young companyFounded 2023
- New on EvolcAdded 2026-11-10
About Cellestial Health
Cellestial Health is a preclinical biopharmaceutical company developing brain-penetrant small molecules designed to stabilise astrocytic networks and address disease progression in Parkinson’s and other neurological conditions.
Its pipeline targets different molecular pathways in astrocytic networks. The company is based in Cambridge, UK, and was founded in 2023.
Product: Preclinical brain-penetrant small-molecule therapeutics targeting astrocytic networks in Parkinson’s and other neurological diseases.
Jobs at Cellestial Health
More biotech & pharma companies
Cellspex
Cell spectroscopy systems and enzyme simulation software for researchers studying mitochondrial bioenergeticsYoung companyNew on EvolcCentauri Therapeutics
Develops Alphamer immunotherapies for infectious diseases, including Gram-negative bacterial infections in high-risk patientsNew on EvolcCerevance
Develops cell-type-specific therapies and drug targets for patients with neurodegenerative, psychiatric and CNS disordersNew on EvolcChemify
Automated chemistry systems that help pharmaceutical and materials partners design and synthesize moleculesNew on EvolcChugai Pharma Europe
European pharmaceutical operations and product support for patients and medical communities across the regionNew on EvolcCiteab
Provides citation-based reagent search and life science data services for researchers and life science suppliersNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Content management
- WordPressHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- Website resourcedeclared script/iframe or software asset
- Website resourcedeclared script/iframe or software asset
Hosting
- nginxHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
- Response headerserver
- Response headerserver
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.